Aspen Neuroscience names new senior vice president of regulatory affairs and quality
14 July 2021 -

Aspen Neuroscience Inc, a private biotechnology company, announced on Tuesday that it has named Ana Sousa as its new senior vice president of regulatory affairs and quality, and as a member of the company's executive team.

Sousa has over 20 years of experience in global development and regulatory affairs combined. She has headed Global Regulatory Affairs and Quality for Principia Biopharma. She has held roles of increased leadership with Immune Design, Onyx Pharmaceuticals, and Genentech-Roche.

Sousa has her undergraduate degree from Pace University, Lubin School of Business, and Master of Science in Jurisprudence degree with a concentration in Health Law and Intellectual Property from The Seton Hall University School of Law.